SciELO - Scientific Electronic Library Online

 
vol.66 issue2Chronic cough. Cough reflex hypersensitivity syndromeFrom research to practice: clinical phases for drug development author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista alergia México

On-line version ISSN 2448-9190

Abstract

LOPEZ-HERNANDEZ, Itzel et al. Chronic granulomatous disease. Update and review. Rev. alerg. Méx. [online]. 2019, vol.66, n.2, pp.232-245. ISSN 2448-9190.  http://dx.doi.org/10.29262/ram.v66i2.577.

Chronic granulomatous disease (CGD) is a primary immunodeficiency syndrome which is characterized by increased susceptibility to severe fungal and bacterial infections. CGD is the result of the lack of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme in the patient’s phagocytes to produce superoxide. It is characterized by recurrent infections with a narrow spectrum of bacteria and fungi, as well as a common set of inflammatory complications, including inflammatory bowel disease. The most frequently found pathogens are Staphylococcus aureus, species of Aspergillus, species of Klebsiella, Burkholderia cepacia, Serratia marcescens and species of Salmonella. Long term antibiotic prophylaxis has helped fight infections associated with chronic granulomatous disease, while the steady progress in bone marrow transplants and the possibility of gene therapy are defined as permanent treatment options.

Keywords : Primary immunodeficiencies; Chronic granulomatous disease; Dihydrorhodamine; Recurrent infections; Defects in phagocytosis.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )